Oncorus Inc (ONCR) Annual Income Statement

Annual · GAAP · USD millions
Access ONCR quarterly income statements →
The data below summarizes Oncorus Inc's income statement results from to Dec 31 2022, enabling period-by-period comparison of operating performance.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
2022
(Dec 31 2021) (Dec 31 2020)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing21.79
Research and Development Expense54.74
Total operating costs including COS76.54
Operating income / -loss-76.54
Interest Expense1.10
Net Interest (-)Expense / Income-1.10
Investment Income, Interest0.00
Other loss / -income-0.21
Total costs & expenses77.42
Income & Taxes
Income / -loss before income taxes-77.42
Income after income taxes-77.42
Income / -loss from continuing operations-77.42
Preferred dividends0.00
Net income / -loss-77.42
Income / -loss to shareholder-77.42
EBIT-76.33
EBITD-72.70
EBITDA-72.70
Earnings Per Share
Basic EPS (excl. extra items)-2.99
Basic Net EPS-2.99
Basic shares outstanding (Mill. of Units)25.92
Diluted Net EPS-2.99
Diluted average shares (Mill. of Units)25.92
4 historic quarters locked

Sign in to unlock the full Oncorus Inc income statement history.

About ONCR Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.